About

Touch to Test technology sets us apart

Your results in minutes

Who We Are

We develop and manufacture “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes. Our patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or in some cases, saliva. We envision a world where people have greater access to in-home testing with in-home results – in minutes. We are committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

Our Leadership

About

Todd Grice

VP of Sales

About

John Miller

Chief Financial Officer

Dr. Jody Berry, Ph.D. / Chief Scientific Officer

About

Dr. Jody Berry, Ph.D.

Chief Scientific Officer

About

Kevin Clark

NOWDx Co-founder

About

Vicki Thompson

Manufacturing Director

Sharon Rabine / Director, Clinical Operations

About

Sharon Rabine

Director, Clinical Operations

About

Michele Roe

Quality Director

About

Robert Weigle

Chief Executive Officer

Dr. Stephen S. Tang, Ph.D., MBA / Board Chairman

About

Dr. Stephen S. Tang, Ph.D., MBA

Board Chairman

10

Countries

14

Distributors

320k

Test Sold

Check out what is making the news

Find out the latest news

More News

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

March 21, 2024

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as th...

Dr. Jody Douglas Berry Joins NOWDx as Chief Scientific Officer

March 14, 2024

SPRINGDALE, Ark., – March 14, 2024 – NOWDiagnostics (NOWDx) today announced the appointment of Jody Douglas Berry, Ph.D. as chief scientific officer (CSO). Dr. Berry, a distinguished scientific leader with over two decades of experience in infectious diseas...

NOWDx Submits De Novo Classification Request to the FDA for Its First to Know™ Over-the-Counter Syphilis Test

January 9, 2024

Company Receives Funding from Labcorp's Venture Fund to Advance Diagnostic Breakthroughs SPRINGDALE, Ark., Jan. 9, 2024 /PRNewswire/ -- NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-cla...